Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma

NCT00617799 · clinicaltrials.gov ↗

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer
Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
GENETIC: gene expression analysis
GENETIC: mutation analysis
OTHER: flow cytometry

Sponsor

University of Nebraska

Collaborators

[object Object]